Action GNFT GENFIT S.A.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Genfit S.A. Nasdaq

Actions

GNFT

US3722791098

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 28/06/2024 		Varia. 5j. Varia. 1 janv.
3,61 USD -6,48% Graphique intraday de Genfit S.A. -6,96% -6,23%
28/06 Les actions européennes négociées aux États-Unis et les American Depositary Receipts sont en légère hausse vendredi matin MT
27/06 Les actions européennes négociées aux États-Unis sous forme de certificats de dépôt américains sont en hausse jeudi matin MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading
Borsa di Italia: inarrestabile
Bolsa de Madrid: Imparable
GENFIT: New EASL EASD EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At Risk MASH
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading
Genfit S.A. Announces the Successful Corporate Milestone with U.S. FDA Accelerated Approval of Ipsen's Iqirvo for Primary Biliary Cholangitis
Borsa di Italia: A Wall Street non importa di Apple e Macron
Bolsa de Madrid: A Wall Street no le importan ni Apple ni Macron
Genfit Partner Ipsen Gets FDA Accelerated Approval for Primary Biliary Cholangitis Treatment
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
US FDA approves Genfit and Ipsen's liver disease drug
European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action GNFT
  4. Action GNFT
  5. Actualités Genfit S.A.
  6. Autres langues